Article
Collaboration of breast cancer clinic and genetic counseling division for BRCA1 and BRCA2 mutation family in Japan.
Breast cancer (Tokyo, Japan) - 1 Jan 2004
Takeda Motohiro, Ishida Takanori, Ohnuki Kohji, Suzuki Akihiko, Sakayori Masato, Ishioka Chikashi, Nomizu Tadashi, Noguchi Shinzaburou, Matsubara Yoichi, Ohuchi Noriaki
Abstract excerpt
BACKGROUND: BRCA1 and BRCA2 mutations cause high breast cancer incidence rates as high as 80% Although prophylactic therapy is still controversial, several prophylactic therapies have been proposed and tried for BRCA1 and BRCA2 mutation carriers. Prophylactic surgery, chemo-prevention and precise screening have been proposed as prophylactic therapy. All BRCA1 and BRCA2 mutation carriers need knowledge about their...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.